Ferhan Qureshi

541 total citations
20 papers, 361 citations indexed

About

Ferhan Qureshi is a scholar working on Rheumatology, Pathology and Forensic Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Ferhan Qureshi has authored 20 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Rheumatology, 10 papers in Pathology and Forensic Medicine and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Ferhan Qureshi's work include Rheumatoid Arthritis Research and Therapies (11 papers), Multiple Sclerosis Research Studies (10 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Ferhan Qureshi is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (11 papers), Multiple Sclerosis Research Studies (10 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Ferhan Qureshi collaborates with scholars based in United States, Australia and Sweden. Ferhan Qureshi's co-authors include Peter Eastman, Claire L. Alexander, William C. Manning, Lyndal K. Hesterberg, Ezogelin Oflazoglu, Walter C. Darbonne, Thomas Gelzleichter, G. Cavet, Sean K. Kelley and Douglas J. Haney and has published in prestigious journals such as Nature Communications, Neurology and British Journal of Pharmacology.

In The Last Decade

Ferhan Qureshi

17 papers receiving 351 citations

Peers

Countries citing papers authored by Ferhan Qureshi

Since Specialization

Citations

This map shows the geographic impact of Ferhan Qureshi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ferhan Qureshi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ferhan Qureshi more than expected).

Fields of papers citing papers by Ferhan Qureshi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ferhan Qureshi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ferhan Qureshi. The network helps show where Ferhan Qureshi may publish in the future.

Co-authorship network of co-authors of Ferhan Qureshi

This figure shows the co-authorship network connecting the top 25 collaborators of Ferhan Qureshi. A scholar is included among the top collaborators of Ferhan Qureshi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ferhan Qureshi. Ferhan Qureshi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Proteomics confirms immune stabilizing effects of narrowband UVB treatment in patients with clinically isolated syndrome and multiple sclerosis 2025 ·Multiple Sclerosis and Related Disorders ·Prue H. Hart, Christopher J. Emig, Ahmed Z. Obeidat, Stephanie Trend, Allan G. Kermode, Ferhan Qureshi, (unknown)	0
2	Real-world clinical utility of a multi-protein, blood-based biomarker assay for disease activity assessments in multiple sclerosis 2025 ·Multiple Sclerosis Journal - Experimental Translational and Clinical ·Angela J. Sanchez, (unknown), (unknown), (unknown), (unknown), Shannon R. McCurdy, (unknown), Ferhan Qureshi, (unknown), Mitzi Williams, (unknown), (unknown), Jacqueline Nicholas, (unknown), (unknown), Jon M. Burnham, Yasir Jassam, (unknown), (unknown)	0
3	Serum Biomarker Signatures of Choroid Plexus Volume Changes in Multiple Sclerosis 2024 ·Biomolecules ·Dejan Jakimovski, Robert Zivadinov, Ferhan Qureshi, Murali Ramanathan, Bianca Weinstock‐Guttman, Eleonora Tavazzi, Michael G. Dwyer, Niels Bergsland	5
4	Proteomic signatures of physical, cognitive, and imaging outcomes in multiple sclerosis 2024 ·Annals of Clinical and Translational Neurology ·Kian Jalaleddini, Dejan Jakimovski, Anisha Keshavan, Shannon R. McCurdy, Kelly M. Leyden, Ferhan Qureshi, Atiyeh Ghoreyshi, Niels Bergsland, Michael G. Dwyer, Murali Ramanathan, Bianca Weinstock‐Guttman, Ralph H. B. Benedict, Robert Zivadinov	7
5	Inflammatory and neurodegenerative serum protein biomarkers increase sensitivity to detect clinical and radiographic disease activity in multiple sclerosis 2024 ·Nature Communications ·Tanuja Chitnis, Ferhan Qureshi, (unknown), Michael J. Becich, Riley Bove, Bruce Cree, Refujia Gomez, Stephen L. Hauser, Roland G. Henry, (unknown), Hrishikesh Lokhande, Anu Paul, Stacy J. Caillier, Adam Santaniello, Neda Sattarnezhad, Shrishti Saxena, Howard L. Weiner, (unknown), Sergio E. Baranzini	10
6	Glial cell injury and atrophied lesion volume as measures of chronic multiple sclerosis inflammation 2024 ·Journal of the Neurological Sciences ·Dejan Jakimovski, Ferhan Qureshi, Murali Ramanathan, Kian Jalaleddini, (unknown), Michael G. Dwyer, Niels Bergsland, Bianca Weinstock‐Guttman, Robert Zivadinov	0
7	A US payer perspective health economic model assessing value of monitoring disease activity to inform discontinuation and re-initiation of DMT in multiple sclerosis 2024 ·Multiple Sclerosis Journal ·Kian Jalaleddini, Robert A Bermel, (unknown), David Weinstein, Ferhan Qureshi, (unknown), (unknown), (unknown), Kesshi Jordan, (unknown), Shannon R. McCurdy, (unknown)	2
8	Lower arterial cerebral blood flow is associated with worse neuroinflammation and immunomodulation composite proteomic scores 2024 ·Multiple Sclerosis and Related Disorders ·Dejan Jakimovski, Ferhan Qureshi, Murali Ramanathan, Anisha Keshavan, Kelly M. Leyden, Kian Jalaleddini, (unknown), Michael G. Dwyer, Niels Bergsland, Karen Marr, Bianca Weinstock‐Guttman, Robert Zivadinov	1
9	Analytical validation of a multi‐protein, serum‐based assay for disease activity assessments in multiple sclerosis 2023 ·PROTEOMICS - CLINICAL APPLICATIONS ·Ferhan Qureshi, (unknown), (unknown), (unknown), (unknown), Michael J. Becich, (unknown), (unknown), Fujun Zhang, John Foley, Tanuja Chitnis	13
10	Proteomics and relationship with axonal pathology in multiple sclerosis: 5-year diffusion tensor imaging study 2023 ·Brain Communications ·Dejan Jakimovski, Ferhan Qureshi, Murali Ramanathan, (unknown), Anisha Keshavan, Kelly M. Leyden, Michael G. Dwyer, Niels Bergsland, Bianca Weinstock‐Guttman, Robert Zivadinov	7
11	Association between serum multi-protein biomarker profile and real-world disability in multiple sclerosis 2023 ·Brain Communications ·Wen Zhu, Chenyi Chen, Lili Zhang, (unknown), (unknown), (unknown), Fujun Zhang, Ferhan Qureshi, John Foley, Zongqi Xia	6
12	Clinical validation of a multi-protein, serum-based assay for disease activity assessments in multiple sclerosis 2023 ·Clinical Immunology ·Tanuja Chitnis, John Foley, Carolina Ionete, (unknown), Shrishti Saxena, (unknown), Hrishikesh Lokhande, Anu Paul, (unknown), Howard L. Weiner, Ferhan Qureshi, Michael J. Becich, (unknown), (unknown), Fujun Zhang, Anisha Keshavan, Kian Jalaleddini, (unknown), Samia J. Khoury	10
13	Association between Serum Biomarker Profile and Real-World Evidence of Disability in Multiple Sclerosis (S9.004) 2023 ·Neurology ·Wen Zhu, Chenyi Chen, Lili Zhang, (unknown), (unknown), Fujun Zhang, Ferhan Qureshi, (unknown), John Foley, Zongqi Xia	1
14	Correlation of serum protein biomarkers with disease activity in psoriatic arthritis 2020 ·Expert Review of Clinical Immunology ·(unknown), Peter Eastman, (unknown), Ferhan Qureshi, Eric H. Sasso, Rebecca Bolce, (unknown), (unknown), D L Boyle, Arthur Kavanaugh	10
15	Serum RANKL levels associate with anti- citrullinated protein antibodies in early untreated rheumatoid arthritis and are modulated following methotrexate 2015 ·Arthritis Research & Therapy ·Aase Hensvold, Vijay Joshua, Wanying Li, (unknown), Ferhan Qureshi, Lena Israelsson, Leonid Padyukov, Karin Lundberg, Nadine A. Defranoux, Saedís Saevarsdóttir, Anca I. Catrina	46
16	Characterization of a multiplex, 12-biomarker test for rheumatoid arthritis 2012 ·Journal of Pharmaceutical and Biomedical Analysis ·Peter Eastman, William C. Manning, Ferhan Qureshi, Douglas J. Haney, G. Cavet, Claire L. Alexander, Lyndal K. Hesterberg	70
17	Pre-analytical effects of blood sampling and handling in quantitative immunoassays for rheumatoid arthritis 2012 ·Journal of Immunological Methods ·Xiaoyan Zhao, Ferhan Qureshi, Peter Eastman, William C. Manning, Claire L. Alexander, William H. Robinson, Lyndal K. Hesterberg	22
18	Preclinical pharmacokinetics, pharmacodynamics and activity of a humanized anti‐CD40 antibody (SGN‐40) in rodents and non‐human primates 2007 ·British Journal of Pharmacology ·Sean K. Kelley, Thomas Gelzleichter, Dong Xie, Wyne P. Lee, Walter C. Darbonne, Ferhan Qureshi, Kim M. Kissler, Ezogelin Oflazoglu, Iqbal S. Grewal	45
19	Preclinical pharmacokinetics, pharmacodynamics, and activity of a humanized anti‐CD40 antibody (SGN‐40) in rodents and non‐human primates 2006 ·British Journal of Pharmacology ·Sean K. Kelley, Thomas Gelzleichter, Dong Xie, Wyne P. Lee, Walter C. Darbonne, Ferhan Qureshi, Kim M. Kissler, Ezogelin Oflazoglu, Iqbal S. Grewal	46
20	Depletion of B Cells by a Humanized Anti-CD20 Antibody PRO70769 in Macaca Fascicularis 2005 ·Journal of Immunotherapy ·Yulia Vugmeyster, Joseph C. Beyer, Kathy Howell, Dan Combs, Paul J. Fielder, Jihong Yang, Ferhan Qureshi, (unknown), (unknown), Wolfgang Dummer, Henry B. Lowman, Kathleen McKeever	60

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact